TARGETED THERAPY FOR MAP2K1 AND MAP2K4 MUTANT ESTROGEN RECEPTOR-POSITIVE BREAST CANCER

$516,773FY2012Department of DefenseDOD

Washington University, The

Investigators

View source on USAspending →